ID24185A - Pelet matriks polietilena glikol untuk bahan obat yang berlemak, berminyak atau lengket - Google Patents

Pelet matriks polietilena glikol untuk bahan obat yang berlemak, berminyak atau lengket

Info

Publication number
ID24185A
ID24185A IDW20000913A ID20000913A ID24185A ID 24185 A ID24185 A ID 24185A ID W20000913 A IDW20000913 A ID W20000913A ID 20000913 A ID20000913 A ID 20000913A ID 24185 A ID24185 A ID 24185A
Authority
ID
Indonesia
Prior art keywords
oil
pelets
polyethylene glycol
medicine materials
complete medicine
Prior art date
Application number
IDW20000913A
Other languages
English (en)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Soderbom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID24185A publication Critical patent/ID24185A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20000913A 1997-11-28 1998-11-18 Pelet matriks polietilena glikol untuk bahan obat yang berlemak, berminyak atau lengket ID24185A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704401A SE9704401D0 (sv) 1997-11-28 1997-11-28 Matrix pellets for greasy, oily or sticky drug substances

Publications (1)

Publication Number Publication Date
ID24185A true ID24185A (id) 2000-07-13

Family

ID=20409178

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000913A ID24185A (id) 1997-11-28 1998-11-18 Pelet matriks polietilena glikol untuk bahan obat yang berlemak, berminyak atau lengket

Country Status (23)

Country Link
US (2) US6555138B1 (id)
EP (1) EP1032371B1 (id)
JP (1) JP2001524514A (id)
KR (1) KR20010032558A (id)
CN (1) CN1280493A (id)
AR (1) AR016684A1 (id)
AT (1) ATE286382T1 (id)
AU (1) AU746324B2 (id)
BR (1) BR9814756A (id)
CA (1) CA2311930A1 (id)
DE (1) DE69828527T2 (id)
HU (1) HUP0004405A3 (id)
ID (1) ID24185A (id)
IL (1) IL136144A0 (id)
NO (1) NO20002720L (id)
NZ (1) NZ504354A (id)
PL (1) PL340926A1 (id)
RU (1) RU2216316C2 (id)
SE (1) SE9704401D0 (id)
SK (1) SK6592000A3 (id)
TW (1) TW570813B (id)
WO (1) WO1999027913A1 (id)
ZA (1) ZA9810465B (id)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
SI1569912T1 (sl) 2002-12-03 2015-09-30 Pharmacyclics Llc Derivati 2-(2-hidroksibifenil-3-il)-1h-benzoimidazol-5-karboksamidina kot inhibitorji faktorja viia
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
EP2114455A4 (en) * 2006-12-20 2010-03-17 Mylan Pharmaceuticals Ulc PHARMACEUTICAL COMPOSITION USING A HOT-MELT GRANULATED AGENT
AU2014201170B2 (en) * 2006-12-20 2015-09-24 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
KR102505172B1 (ko) 2013-09-19 2023-02-28 마이크로벤션, 인코포레이티드 중합체 필름
AU2014321277B2 (en) 2013-09-19 2017-07-20 Terumo Corporation Polymer particles
CA2929235C (en) 2013-11-08 2018-07-17 Terumo Corporation Polymer particles
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
KR102310696B1 (ko) 2016-09-28 2021-10-12 테루모 가부시키가이샤 색전 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE557670C (de) 1932-08-26 Friedrich Rittershausen Abtast- bzw. Bildzusammensetzvorrichtung
DE454386C (de) 1924-05-27 1928-01-06 Chemische Produkte Vormals H S Verfahren zur Herstellung pharmazeutischer und diaetetischer Praeparate in kugelaehnlicher Form
US2699054A (en) 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
DE2251197C3 (de) 1972-10-19 1980-05-08 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von hxxochdosierten Tabletten von Tetracyclin- Derivaten
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
US5876754A (en) * 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
ES2092808T3 (es) * 1992-01-17 1996-12-01 Alfatec Pharma Gmbh Cuerpos solidos con contenido en principio activo con una estructura a base de macromoleculas hidrofilas y procedimiento para su produccion.
EP0557670B1 (de) * 1992-02-25 1999-05-06 Spirig Ag Pharmazeutische Präparate Minocyclin enthaltende Pellets
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances

Also Published As

Publication number Publication date
AU746324B2 (en) 2002-04-18
NZ504354A (en) 2001-12-21
PL340926A1 (en) 2001-03-12
RU2216316C2 (ru) 2003-11-20
CN1280493A (zh) 2001-01-17
JP2001524514A (ja) 2001-12-04
CA2311930A1 (en) 1999-06-10
ZA9810465B (en) 1999-05-21
DE69828527D1 (de) 2005-02-10
US20030175352A1 (en) 2003-09-18
KR20010032558A (ko) 2001-04-25
IL136144A0 (en) 2001-05-20
EP1032371A1 (en) 2000-09-06
NO20002720D0 (no) 2000-05-26
SE9704401D0 (sv) 1997-11-28
AU1356499A (en) 1999-06-16
NO20002720L (no) 2000-07-28
SK6592000A3 (en) 2001-01-18
DE69828527T2 (de) 2005-12-29
WO1999027913A1 (en) 1999-06-10
EP1032371B1 (en) 2005-01-05
HUP0004405A3 (en) 2004-03-29
ATE286382T1 (de) 2005-01-15
BR9814756A (pt) 2000-10-03
HUP0004405A2 (hu) 2001-08-28
AR016684A1 (es) 2001-07-25
US6555138B1 (en) 2003-04-29
TW570813B (en) 2004-01-11

Similar Documents

Publication Publication Date Title
ID24185A (id) Pelet matriks polietilena glikol untuk bahan obat yang berlemak, berminyak atau lengket
ID19979A (id) Komposisi polietilena berisi
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
DE69738238D1 (de) Epoxy-polysiloxan polymerzusammensetzung
DE69808253D1 (de) Zerlegbarer behälter
DE69827462D1 (de) Hüftschaft-Zementabstandshalter
DE69827987D1 (de) Verpackungsmaterial
TR199802624A3 (tr) Yeni farmasötik.
ID17774A (id) Komposisi farmasi antitrombosis
BR9710479A (pt) Recipiente para manter elementos esterilizados
ID20818A (id) Wadah penyalur
ID29294A (id) Komposisi farmasi
BR9709406B1 (pt) fluorenonas alquiloxiamino substituìdas e composição farmacêutica contendo as mesmas.
MA26531A1 (fr) Composition pharmaceutique
DE69803996D1 (de) Verpackungsmaterial
ID25857A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
DE69805291D1 (de) Teilcheförmiges hydrogelmaterial
FR2769234B1 (fr) Composition de decontamination
DE69812129D1 (de) Gelmaterialien
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi
ITBO970237A0 (it) Struttura protettiva per contenitori di rifiuti.
FI962036A (fi) Lääkesäiliö